Financial News
All News about Nanoviricides Inc
NanoViricides COVID-19 Treatment Candidate Found Effective Against Coronavirus Variants In Lab Study
October 11, 2021
Via Benzinga
Exposures
COVID-19
From NanoViricides, Inc.
Via AccessWire
EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
September 21, 2021
Via Benzinga
Exposures
COVID-19
53 Biggest Movers From Yesterday
September 16, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact
September 14, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.